Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant

Pediatric Transplantation

Volumn 11, Issue 2, 2007, Pages 214-216

  Kuskonmaz, B ^a   Gucer S ^a   Boztepe, G ^a   Cetin, M ^a   Uckan, D ^a,b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b HaceHepe University Children's Hospital   (Turkey)

Author keywords

Bone marrow transplantation; Dermatitis; Graft vs. host disease; Skin GVHD

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; FLUCONAZOLE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CAUSE OF DEATH; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAPER DERMATITIS; ENTEROPATHY; ERYTHEMA; HLA MATCHING; HUMAN; HYPERKERATOSIS; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFANT DISEASE; LIVER DISEASE; MALE; MALIGNANT NEOPLASTIC DISEASE; OSTEOPOROSIS; SKIN MANIFESTATION; SKIN NODULE;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; DISEASE PROGRESSION; EPIDERMIS; FATAL OUTCOME; GRAFT VS HOST DISEASE; HUMANS; INFANT; MALE; OSTEOPETROSIS; SKIN DISEASES;

EID: 33846592413     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00647.x     Document Type: Article

References (12)

1. BOLANOS-MEADE J. Update on the management of acute graft-versus-host disease. Curr Opin Oncol 2006: 18: 120-125.
2. VARGAS-DIEZ E, FERNANDEZ-HERRERA J, MARIN A, CAMARA R, GARCIA-DIEZ A. Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation. Br J Dermatol 2003: 148: 1129-1134.
3. CHAUDHURI SP, SMOLLER BR. Acute cutaneous graft versus host disease: A clinicopathologic and immunophenotypic study. Int J Dermatol 1992: 31: 270-272.
4. DEEG HJ, STORB R. Graft-versus-host disease: Pathophysiological and clinical aspects. Annu Rev Med 1984: 35: 11-24
5. SAURAT JH. Cutaneous manifestations of graft-versus-host disease. Int J Dermatol 1981: 20: 249-256.
6. STORB R, PRENTICE RL, BUCKNER CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983: 308: 302-327.
7. SANLI H, EKMEKCI P, ARAT M, GURMAN G. Clinical manifestations of cutaneous graft-versus-host disease after allogeneic haematopoietic cell transplantation: Long-term follow-up results in a single Turkish centre. Acta Derm Venereol 2004: 84: 296-301.
8. ARSLAN O, USTUN C, ARAT M et al. Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia. Hematol Oncol 1998: 16: 155-162.
9. JOHNSON ML, FARMER ER. Graft-versus-host reactions in dermatology. J Am Acad Dermatol 1998: 38: 369-392
10. ARACTINGI S, CHOSIDOW O. Cutaneous graft-versus-host disease. Arch Dermatol 1998: 134: 602-612.
11. RUIZ-GENAO DP, GF-VILLALTA MJ, PENAS PF, FRAGA J, GARCIA-DIEZ A, FERNANDEZ-HERRERA J. Pustular acral erythema in a patient with acute graft-versus-host disease. J Eur Acad Dermatol Venereol 2003: 17: 550-553.
12. KOSSARD S, MA DD. Acral keratotic graft versus host disease simulating warts. Australas J Dermatol 1999: 40: 161-163.